Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-09 @ 4:50 PM
Study NCT ID:
NCT01432951
Status:
COMPLETED
Last Update Posted:
2020-10-12
First Post:
2011-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2013-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-09
First Submit QC Date:
None
Study First Post Date:
2011-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-17
Results First Submit QC Date:
None
Results First Post Date:
2020-09-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-14
Last Update Post Date:
2020-10-12
Last Update Post Date Type:
ACTUAL